Here is how Next PLC (NXGPY) and Prosus N.V. Sponsored ADR (PROSY) have performed compared to their sector so far this year.
Vous n'êtes pas connecté
GSK plc and CureVac N.V. announced they have restructured their existing collaboration into a new licensing agreement, allowing each company to prioritize investment and focus their respective mRNA development activities. Since 2020, GSK and CureVac have worked together to develop mRNA vaccines for infectious diseases. Through this collabora...
Here is how Next PLC (NXGPY) and Prosus N.V. Sponsored ADR (PROSY) have performed compared to their sector so far this year.
Cranfield University researchers have created a low-cost origami-paper sensor to detect wastewater biomarkers, allowing mobile phone tracking of...
INFECTIOUS disease specialist Dr Peter Chin Hong says other than not being vaccinated, the biggest threat to people in this phase of covid19 is...
The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during...
THE Prime Minister and the Energy Minister have both said Government is continuing to aggressively pursue initiatives inside and outside of TT's...
The Department of Health (DOH) is expediting the procurement of flu vaccines, reiterating the importance of prevention, including regular hand...
The respiratory season is approaching and Hastings Prince Edward Public Health is preparing to offer flu and COVID-19 vaccines. Immunization Nurse...
In the first quarter of 2023, over 700 manufacturing companies in Nigeria closed their doors, highlighting a significant crisis in the sector,...
WASHINGTON (AP) — Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older adults...
Fall means it's time for just about everybody to get up to date on their flu and COVID-19 vaccines - and a lot of older adults also need protection...